Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Companies prioritize efficiency, innovation, and team synergy in hiring strategies, reveals GlobalData

Companies across various industries are increasingly prioritizing efficiency, product development, and business expansion in their hiring strategies. This approach aims to bolster organizational effectiveness. There is also a concerted effort to elevate customer experience, foster innovation and drive performance. Meanwhile many organizations are consolidating departments to create new unified, synergistic teams, reveals GlobalData, a leading […]
Read more

Merck seeks to develop novel T-cell engager therapies with TriTAC platform, says GlobalData

Merck has recently agreed to acquire cancer drug developer Harpoon Therapeutics for about $680 million. The deal includes promising compounds undergoing Phase II trials for malignancies and access to the Tri-specific T cell Activating Construct (TriTAC) platform, positioning the US-based pharmaceutical giant for significant advancements in therapeutic innovation. The focus lies on contesting the evolving […]
Read more

Diagnostic imaging to see advances in AI, imaging agents, and ultrasound technology in 2024, says GlobalData

The surging global aging population and escalating disease prevalence, notably cancer, are propelling a heightened demand for imaging. Diagnostic imaging is undergoing a transformative R&D phase, with a focus on software, hardware, and consumables tailored for early disease diagnosis and personalized medicine applications. The recent strides in artificial intelligence (AI), imaging agents, and ultrasound technology […]
Read more

Netflix sentiment soars in 2023 with new ad plan, gaming expansion and strategic moves, reveals GlobalData

Netflix‘s sentiment soared in 2023, fueled by strategies including a new advertising plan, the introduction of paid sharing options, and a dynamic expansion into the gaming sector. This surge is underpinned by a remarkable increase in monthly active users (MAUs) and the successful diversification of its entertainment offerings, reveals GlobalData, a leading data and analytics […]
Read more

Mazdutide positive phase III results to help Innovent gain widespread adoption in China obesity market, says GlobalData

Innovent Biologics has recently made a significant breakthrough in obesity treatment with mazdutide, showcasing promising Phase III (GLORY-1) results. Poised to enter the Chinese market, mazdutide heralds a new era in obesity management, reflecting the China-based biotech company’s commitment to innovative healthcare solutions and addressing the growing need for effective obesity treatments in one of […]
Read more

Influencers cautiously upbeat on cloud and AI prospects amid Microsoft record earnings, reveals GlobalData

Microsoft’s Q4 2023 results reveal a record-breaking revenue of $62 billion, indicating an impressive 18% year-over-year surge that surpasses financial forecasts and sets a new high. However, despite these accomplishments, influencers on the “X” platform express cautious optimism, considering the company’s achievements in the cloud services sector and the challenge of meeting high investor expectations. […]
Read more

Despite argenx Vyvdura approval, quest for definitive myasthenia gravis cure persists in Japan, says GlobalData

Japan has recently approved argenx’s  Vyvdura (efgartigimod alfa and hyaluronidase-qvfc) subcutaneous (SC) injection for the treatment of adult patients with generalized myasthenia gravis (gMG), who do not have sufficient response to steroids or non-steroidal immunosuppressive therapies (ISTs). While introducing a novel subcutaneous administration route, Vyvdura adds to Japan’s myasthenia gravis (MG) treatment options. However, differentiation […]
Read more
1 … 76 77 78 79 80 … 209